Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
8,369,327
-
Shares change
-
+1,805,730
-
Total reported value, excl. options
-
$127,297,422
-
Value change
-
+$33,779,392
-
Put/Call ratio
-
79%
-
Number of buys
-
48
-
Number of sells
-
-25
-
Price
-
$15.21
Significant Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q3 2024
107 filings reported holding CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock as of Q3 2024.
CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,369,327 shares
of 45,782,552 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,750,007 shares), VANGUARD GROUP INC (1,576,541 shares), GEODE CAPITAL MANAGEMENT, LLC (638,189 shares), STATE STREET CORP (512,313 shares), SUPERSTRING CAPITAL MANAGEMENT LP (337,347 shares), Ikarian Capital, LLC (300,000 shares), Altium Capital Management LP (285,000 shares), NORTHERN TRUST CORP (268,071 shares), Point72 Asset Management, L.P. (250,204 shares), and OSAIC HOLDINGS, INC. (240,750 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.